BRAF and metastatic malignant neoplasm in the lymph nodes: Prior studies on the association between BRAF V600E and PTC aggressiveness have yielded inconsistent conclusions: most reports link BRAF positivity to adverse outcomes such as lymph node metastasis, whereas some studies found no significant association, leaving the conclusions controversial [25,27,28,35,36].